Description

I am a Global Chief Financial Officer (CFO) and strategic operating executive with over 25 years of experience driving financial transformation, M&A integration, and sustainable value creation. I have served as a trusted C-suite advisor and Fractional CFO for global organizations, ranging from PE-backed portfolio companies to $15.2B enterprises and international NGOs.

I bring the agility of a Private Equity operator to help leadership teams execute complex turnarounds, achieve rapid EBITDA gains, and deliver 100-day value creation plans. Having managed operating budgets of up to $1B and global teams across 35 countries, I excel in aligning financial strategy with overarching operational goals in complex environments. Core areas where I deliver immediate impact include:

Strategic Financial Leadership: Serving as an Interim CFO/Controller to drive P&L management, establish robust internal controls, and optimize working capital.

M&A & Transactional Leadership: Leading buy-side due diligence, IPO readiness, post-merger integrations, and synergy realization to maximize enterprise valuation.

EBITDA Expansion & Cost Optimization: Identifying supply chain inefficiencies, reducing COGS, and executing strategies that have generated over $500M in sustainable value.

Global Systems Implementation: Spearheading major ERP deployments (SAP, Oracle, Hyperion) to enhance data visibility and valuation metrics across the supply chain.

Fluent in Spanish and highly experienced in cross-border negotiations, I partner closely with PE sponsors, Boards of Directors, and executive teams to navigate complex financial landscapes and achieve high-multiple exits. I provide the technical acumen and leadership required to accelerate growth, scale operations, and protect your investments

Languages

English
Native or bilingual
Spanish
Conversational

Workplace preferences

Can work on-site

New York (up to 50km)

North Highland
Managing Director Supply Chain and Operations
CONSULTING AND AUDITS
July 2025 - Today (11 months)
New York, United States
>Spearhead the Supply Chain Practice, defining the strategic vision to drive complex financial and operational transformation for global manufacturing, consumer healthcare, and life science entities.
>Advise PE sponsors and portfolio companies on global manufacturing footprint optimization, vendor selection, and end-to-end supply chain resilience to protect and enhance multi-sector investments.
> Drive rapid EBITDA expansion initiatives by identifying operational inefficiencies, reducing COGS, and implementing robust S&OP financial controls across decentralized global networks.
Cross-Border Leadership & Multilingual Negotiations ERP & Financial Systems Implementation Large-Scale ERP & Financial Systems Implementation: M&A Due Diligence & Post-Merger Integration Rapid EBITDA Enhancement & Financial Turnarounds
Alvarez and Marsal
Managing Director PE Diversified Industries
CONSULTING AND AUDITS
June 2023 - July 2025 (2 years and 1 month)
New York, United States
>Visionary leader who co-founded a specialized cross-industry practice, driving strategic direction and advising Private Equity sponsors on complex deal structures, including M&A, joint ventures, and alliances within the healthcare, consumer, and manufacturing sectors.
>Executed 100-day value creation plans and post-merger integrations for newly acquired portfolio companies, ensuring rapid synergy realization and financial optimization across diverse product lines.
>Consistently delivered impactful strategic consulting solutions grounded in robust financial, cash-flow, and risk management principles for mid-market and enterprise clients
Latham Biopharm Group (SIA Partners)
Managing Director Healthcare/Consumer Goods/Biotech
CONSULTING AND AUDITS
June 2019 - June 2023 (4 years)
New York, United States
>Delivered impactful results as an interim CFO/Controller for organizations ranging from $30MM to $15.2B, directing PE and VC-backed portfolio companies in highly regulated sectors.
>Drove financial turnarounds, rapid EBITDA growth, and successful fundraising by leveraging advanced modeling to position manufacturing, healthcare, and tech assets for high-multiple exits.
>Provided strategic international tax solutions, rigorous sponsor reporting, and long-range financial planning across 20+ global markets